{"nct_id":"NCT02613403","title":"Efficacy and Safety of Grazoprevir (+) Uprifosbuvir (+) Ruzasvir (MK-3682B) (MK-5172 + MK-3682 + MK-8408) Fixed Dose Combination in Chronic HCV Participants Failing Prior Antiviral Treatment (MK-3682-021)","status":"TERMINATED","status_verified_date":"2024-05","start_date":"2015-12-10","start_date_type":"ACTUAL","primary_completion_date":"2017-01-09","primary_completion_date_type":"ACTUAL","completion_date":"2017-03-27","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["MRK"]}